
BRINGING CONTINUOUS DATA TO THERAPY MANAGEMENT
Injectsense exists at the intersection of advanced semiconductor technology and medical systems.
We develop implant-based digital health systems to provide medical staff with continuous long-term data for improved therapy management.
OUR DNA
Combining the Best of Microelectronics and Medical Devices
Injectsense stands apart from other device developers thanks to its deep roots in two worlds: semiconductor and medical systems. We combine years of hands-on engineering experience in advanced microtechnology -- including ultra-low power IC design, telemetry and miniaturization -- with medical market, regulatory, software, and device expertise.
Our cross-functional approach has bridged these domains, yielding a number of innovative patent-pending solutions. Our Silicon Valley technical team has years of design and fabrication experience in semiconductor, wireless communications, and wafer-scale volume manufacture, while our Twin Cities team brings decades of commercial medical system and software development.

INVESTMENT
Partnering with Major Strategics

Injectsense received a multimillion dollar Series B round from a strategic investor in April 2019 for development and testing of its sensor-enabled digital health system. It is currently engaged in raising funds for Series C.
The company currently has multimillion dollar revenues for product engineering from its corporate partners.
